MAPT and Alzheimer disease: Many AD changes other than amyloid and tau pathology have been reported in these mouse models (APOE4/5xFAD or APOE4/PS19) such as dysfunction in lipid metabolism and immune systems, highlighting the importance of incorporating APOE4 genotype into the studies of AD pathological processes.